GCP
REGN icon

Garda Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Garda Capital Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,200
Closed -$1.26M – 456
2024
Q3 		$1.26M Hold
1,200
– – 0.04% 378
2024
Q2 		$1.26M Buy
+1,200
New +$1.16M 0.04% 313
2024
Q1 		– Sell
-2,300
Closed -$2.02M – 544
2023
Q4 		$2.02M Sell
2,300
-1,200
-34% -$988K 0.17% 140
2023
Q3 		$2.88M Buy
+3,500
New +$2.75M 0.13% 151
2023
Q2 		– Sell
-1,500
Closed -$1.23M – 459
2023
Q1 		$1.23M Sell
1,500
-6,000
-80% -$4.53M 0.06% 222
2022
Q4 		$5.41M Buy
+7,500
New +$5.53M 0.3% 98

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return